Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meldonium and PUFA Supplementation in Healthy Volunteers
NCT07304921Phase 1Completed
- Sponsor
- Rīga Stradiņš University
- Start
- Apr 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of meldonium and omega-3-acid triglycerides (3 arms), sponsored by Rīga Stradiņš University. Primary endpoints: Changes in the plasma concentrations of EPA and DHA at 8 weeks, Changes in plasma acetylcarnitine concentrations at 8 weeks and 2 more. Started Apr 2023; status: completed.
02
Drugs
meldoniumomega-3-acid triglycerides
Beyond the preview
Go deeper on NCT07304921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07304921.